RE:RE:RE:RE:RE:RE:RE:Beam Therapeutics Phase 1 CAR-T study placed on hold by FDA " swing trader"?
perhaps you are over reacting.
I did say I have owned Onc on & off since 1998.
The bulk of my holdings have been since when Matt took over for retired Brad T.
lost track of dates, but I believe 2017.
when I " bought back in"
That was not long before the A.N. Announcement.
I have bought more, last few months, notably when it was bellow $1 on the NAS.
And yes, I did sell SOME into the spikes.
point being a very small % of my total holdings.
Why do I continue to hold Onc & not sell all? Even Dec 2019, when there was a reasonable spike?
I truly believe in the science.
I have read 90%++ of SEDAR documents, log into every on- line meeting available.study the published abstracts.etc etc
I truly believe that between Co- development trails & support that Onc has with Roche, Pfizer, Incyte, Merck etc, that there should be something that comes out of this.
Why would I sell some on spikes? & buy back in in dips ?
To lower my break even costs. & balance my overall risk.
One way or the other, I'm in this until a deal is done.
A complete buyout, would make the decision for me.
A partnership ? I'd sell some....depending on SP & operational details.
I can not be any more clear than that.
Miles from supisious unless the reader is paranoid.
Now, that I have that off my chest. Back to Onc.....
The Q2 results, typically last 6/7 years has been first week of Aug.
the one time it was delayed ( as in this month being second time), when they announced the start of Bracelet trial with Pfizer.
IMHO ( suspicious), They will need to address the final enrolment of Bracelet, either during or before Q2.
My prediction FWIW, next Tuesday.
the only thing suspicious is why they have not discussed final enrolment?